OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 (860) 240-0200
http://www.cga.ct.gov/ofa
sSB-307
AN ACT CONCERNING MEDICAID COVERAGE OF BIOMARKER
TESTING.
Primary Analyst: ES 4/8/24
Contributing Analyst(s): LD
Reviewer: RW
OFA Fiscal Note
State Impact: See Below
Municipal Impact: None
Explanation
The bill requires Medicaid coverage of biomarker testing and
conditions such as coverage on certain medical and scientific evidence.
As such testing is currently covered, and the bill maintains prior
authorization and medical necessity as a potential condition, the bill is
not anticipated to result in a fiscal impact to the Department of Social
Services (DSS). However, to the extent DSS conditions coverage on a
more expansive basis, beyond the current definition of medical
necessity, the state would incur increased Medicaid costs.
The Out Years
The annualized ongoing fiscal impact identified above would
continue into the future subject to the conditions on which biomarking
testing is covered.